Health and Healthcare

Incyte : INCY

All Incyte Articles

136 Articles

Lee Jackson | Jan 31, 2019 at 7:40 AM EST

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies…

Jon C. Ogg | Jan 16, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Apache, Caesars, Dell, Devon Energy, HPE, NetApp, Nordstrom, MetLife, Snap and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apache, Caesars Entertainment, Dell Technologies, Devon Energy, Hewlett Packard…

Chris Lange | Oct 4, 2018 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a down day for the broad U.S. markets, with each of the major indices notching a loss in…

Chris Lange | Sep 8, 2018 at 7:10 AM EDT

Major Biopharma Catalysts on September’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food…

Lee Jackson | Aug 15, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AutoZone, Chipotle, Diamondback Energy, Hasbro, Papa John’s, Western Digital and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AutoZone, Chipotle Mexican Grill, Diamondback Energy, Hasbro, Papa…

Lee Jackson | Aug 10, 2018 at 8:50 AM EDT

5 Stocks That the Top Hedge Funds Are Loading Up On

These are five stocks that the top hedge funds are buying, none of which is an overbought and crowded tech…

Jon C. Ogg | Aug 1, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford,…

Chris Lange | Jun 26, 2018 at 4:08 PM EDT

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the broad U.S. markets with each of the major exchanges recovering, if only slightly,…

Chris Lange | Apr 20, 2018 at 10:35 AM EDT

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their…

Chris Lange | Apr 12, 2018 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was another positive day for the broad U.S. markets. Although markets were solid throughout the day, there was a…

Paul Ausick | Apr 9, 2018 at 4:04 PM EDT

Acadia, Incyte Show the Way to Monday’s 52-Week Low Club

Acadia Pharmaceuticals, Veo, Sibanye Gold, and Incyte Pharmaceuticals all posted new 52-week lows Monday.

Jon C. Ogg | Apr 9, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

The top analyst upgrades, downgrades and other research calls from Monday include Alcoa, CEMEX, Comerica, Facebook, General Motors, Incyte, Proofpoint…

Jon C. Ogg | Apr 7, 2018 at 10:00 AM EDT

Credit Suisse Has 8 Top Stock Picks With at Least 50% Implied Upside

24/7 Wall St. perused all 86 picks from the Credit Suisse top picks list and picked out the few names…

Paul Ausick | Apr 6, 2018 at 4:04 PM EDT

Incyte, NewLink Genetics Crash into Friday’s 52-Week Low Club

Incyte, NewLink Genetics, McDermott International, and Williams Companies all posted new 52-week low Friday.

Chris Lange | Apr 6, 2018 at 10:05 AM EDT

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage…

1 2 3 4 5 … 10

Incyte : INCY

All Incyte Articles

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Top Analyst Upgrades and Downgrades: Apache, Caesars, Dell, Devon Energy, HPE, NetApp, Nordstrom, MetLife, Snap and More

Thursday’s Biggest Winners and Losers in the S&P 500

Major Biopharma Catalysts on September’s FDA Calendar

Top Analyst Upgrades and Downgrades: AutoZone, Chipotle, Diamondback Energy, Hasbro, Papa John’s, Western Digital and More

5 Stocks That the Top Hedge Funds Are Loading Up On

Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

Tuesday’s Biggest Winners and Losers in the S&P 500

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Thursday’s Biggest Winners and Losers in the S&P 500

Acadia, Incyte Show the Way to Monday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

Credit Suisse Has 8 Top Stock Picks With at Least 50% Implied Upside

Incyte, NewLink Genetics Crash into Friday’s 52-Week Low Club

What Has Tanked Incyte and NewLink Genetics

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Incyte : INCY

All Incyte Articles

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Top Analyst Upgrades and Downgrades: Apache, Caesars, Dell, Devon Energy, HPE, NetApp, Nordstrom, MetLife, Snap and More

Thursday’s Biggest Winners and Losers in the S&P 500

Major Biopharma Catalysts on September’s FDA Calendar

Top Analyst Upgrades and Downgrades: AutoZone, Chipotle, Diamondback Energy, Hasbro, Papa John’s, Western Digital and More

5 Stocks That the Top Hedge Funds Are Loading Up On

Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

Tuesday’s Biggest Winners and Losers in the S&P 500

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Thursday’s Biggest Winners and Losers in the S&P 500

Acadia, Incyte Show the Way to Monday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

Credit Suisse Has 8 Top Stock Picks With at Least 50% Implied Upside

Incyte, NewLink Genetics Crash into Friday’s 52-Week Low Club

What Has Tanked Incyte and NewLink Genetics

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026